A carregar...
Development of Levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis
Inhaled therapies allow for the targeted delivery of antimicrobials directly into the lungs and have been widely used in the treatment of cystic fibrosis (CF) acute pulmonary exacerbations. Nebulized levofloxacin solution (MP-376) is a novel therapy that is currently being evaluated in phase I, II,...
Na minha lista:
| Publicado no: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564390/ https://ncbi.nlm.nih.gov/pubmed/24334337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465813508445 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|